Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.311
Delayed Data
As of 2:16pm ET
 -0.019 / -5.76%
Today’s Change
0.03
Today|||52-Week Range
0.35
+42.01%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.33
Today’s open0.33
Day’s range0.31 - 0.33
Volume19,700
Average volume (3 months)68,751
Market cap$14.6M
Dividend yield--
Data as of 2:16pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-106.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-52.01%
P/E ratio--
Price/Sales1.93
Price/Book1.41

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$8.4M
Annual profit (last year)-$1.1M
Net profit margin-13.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Chief Financial &
Accounting Officer, VP-Finance
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts